LiraglutidevsLL-37
Liraglutide vs LL-37 — independent comparison of uses, administration, pricing across providers, and key differences. Last reviewed April 21, 2026.
Quick Verdict
Based on clinical evidence and real patient data
A GLP-1 receptor agonist administered daily for chronic weight management. FDA-approved as Saxenda for obesity and as Victoza for type 2 diabetes. One of the first GLP-1 medications widely used for weight loss before semaglutide.
The only known human cathelicidin antimicrobial peptide, naturally produced by immune cells and epithelial tissues. LL-37 has broad-spectrum antimicrobial activity alongside potent immunomodulatory and wound-healing properties.
Best choice depends on your insurance, budget, and treatment history.Take the quiz to get a personalized recommendation.
Liraglutide vs LL-37: At a Glance
Full comparison across all key factors.
| Factor | LiraglutideALLY PICK | LL-37 |
|---|---|---|
| Category | weight-loss | recovery |
| Also Known As | Saxenda, Victoza | Cathelicidin, hCAP18/LL-37 |
| Administration | Subcutaneous injection (daily) | Topical or subcutaneous injection |
| Prescription | Required | Required |
| Providers | 4 providers✓ Better | 3 providers |
| Common Uses |
|
|
Data sourced from FDA prescribing information and peer-reviewed clinical trials. Prices reflect telehealth platform costs as of April 21, 2026. See our methodology.
Pricing by Provider
1 provider offers both Liraglutide and LL-37.
| Provider | Liraglutide | LL-37 | Consultation | Lab Testing |
|---|---|---|---|---|
 | $220/monthly | $180/monthly | Video Telehealth | Yes |
 | Not offered | $50/one-time | Async Telehealth | No |
 | $299/monthly | Not offered | Video Telehealth | Yes |
 | $250/monthly | Not offered | Video Telehealth | Yes |
 | $200/monthly | Not offered | Video Telehealth | No |
 | Not offered | $240/monthly | Video Telehealth | Yes |
Key Differences
Liraglutide
More ProvidersA GLP-1 receptor agonist administered daily for chronic weight management. FDA-approved as Saxenda for obesity and as Victoza for type 2 diabetes. One of the first GLP-1 medications widely used for weight loss before semaglutide.
LL-37
The only known human cathelicidin antimicrobial peptide, naturally produced by immune cells and epithelial tissues. LL-37 has broad-spectrum antimicrobial activity alongside potent immunomodulatory and wound-healing properties.
Which Is Right for You?
Choose Liraglutideif…
- You want a weight-loss medication
- You prefer subcutaneous injection (daily) administration
- You want more provider options (4 available)
- Your primary goal is weight loss
- Your primary goal is appetite suppression
Choose LL-37if…
- You want a recovery medication
- You prefer topical or subcutaneous injection administration
- 3 providers available on our platform
- Your primary goal is antimicrobial defense
- Your primary goal is chronic wound healing
Frequently Asked Questions
What is the difference between Liraglutide and LL-37?
Which is cheaper, Liraglutide or LL-37?
Can I switch from Liraglutide to LL-37?
Medical Disclaimer
This comparison is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual results may vary. The information presented reflects publicly available data and may not account for your specific health situation.